Company Overview of A. Menarini Industrie Farmaceutiche Riunite Srl
A. Menarini Industrie Farmaceutiche Riunite Srl researches and manufactures pharmaceutical products. It offers products in the areas of allergology, andrology, anti-infective, cardiovascular, gastrointestinal disorders, gynecology and women's wellness, pain, trauma, headaches, respiratory, rheumatology/osteoporosis, flu, coughs and cold, dermatology and personal care, energy supplements and multivitamins, dietary, iron, milk for infants, and other products. The company sells its products through a network of agents, distributors, and local partners internationally. A. Menarini Industrie Farmaceutiche Riunite Srl was formerly known as Farmacia Internazionale Menarini. The company was founded ...
Via Dei Sette Santi 1/3
Florence, FI 50131
Founded in 1886
Key Executives for A. Menarini Industrie Farmaceutiche Riunite Srl
Corporate Licensing & Business Development Director
Compensation as of Fiscal Year 2017.
A. Menarini Industrie Farmaceutiche Riunite Srl Key Developments
Chugai and Menarini Group Sign Global Licensing Agreement for Oncology Candidate PA799
Nov 29 16
Chugai and Menarini Group have entered into a global licensing agreement for oncology candidate PA799. Under the agreement, Menarini Group will receive the exclusive global licence for the production, development, and marketing of PA799, although Chugai will receive upfront, milestone, and royalty payments from the Menarini Group.
Orion Corporation and Menarini Group Collaborate on Budesonide-Formoterol Easyhaler Combination Product for Asthma and COPD
Sep 7 16
Orion Corporation announced that it has entered into a collaboration agreement with Menarini Group for the co-marketing of budesonide-formoterol Easyhaler combination product in Germany, Italy, Spain, and Portugal. In addition, the parties have agreed on an exclusive license and distribution arrangement in France and Turkey. Both companies will market budesonide-formoterol Easyhaler® for the treatment of asthma and COPD under their own brands accompanied by the Easyhaler® umbrella brand, as applicable. Respiratory is one of the key strategic areas for Menarini. The collaboration with Menarini reinforces Orion’s presence throughout Europe and is in line with Orion’s strategy to strengthen its marketing position in Europe and the sales coverage through partnerships. The co-marketing area – in which both companies present their own product brands under the Easyhaler® umbrella brand – covers Germany, Italy, Spain, and Portugal. Orion will retain exclusive marketing rights for the Nordic countries, U.K. and Eastern Europe where the company is currently promoting Easyhaler® products. Orion will manufacture the budesonide-formoterol Easyhaler® product covered by the agreement.
A. Menarini I.F.R. (Italy) Presents at BIO Trinity 2016, Apr-25-2016
Apr 22 16
A. Menarini I.F.R. (Italy) Presents at BIO Trinity 2016, Apr-25-2016 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|